{"id":"spect","rwe":[{"pmid":"41912136","year":"2026","title":"Gated SPECT Imaging of Left Ventricular Mechanical Dyssynchrony: Predictive Value in Cardiac Resynchronization Therapy Candidates.","finding":"","journal":"Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology","studyType":"Clinical Study"},{"pmid":"41911406","year":"2026","title":"Gallium-67 SPECT/CT Detection of Lower Extremity Muscle Abscess in Vibrio vulnificus Infection.","finding":"","journal":"Clinical nuclear medicine","studyType":"Clinical Study"},{"pmid":"41908703","year":"2026","title":"Nuclear Medicine in Depression: Insights into Brain Metabolism and Treatment Responses: a Literature Review.","finding":"","journal":"Nuclear medicine and molecular imaging","studyType":"Clinical Study"},{"pmid":"41907604","year":"2026","title":"Clinical efficacy of (99m)Tc-MIBI SPECT/CT compared with CBCT in lung biopsies: a retrospective cohort study.","finding":"","journal":"Frontiers in oncology","studyType":"Clinical Study"},{"pmid":"41907062","year":"2026","title":"Discordance Between Striatal Dopaminergic Imaging and Motor Performances in REM Sleep Behavior Disorder.","finding":"","journal":"Neurology open access","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Tomsk National Research Medical Center of the Russian Academy of Sciences","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["99mTc-ZHER2:41071","[123I] I-(HE)3-G3"],"company":"Tomsk National Research Medical Center of the Russian Academy of Sciences","patents":[],"pricing":[],"allNames":["spect"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"target":"30S ribosomal protein S12","modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and Spect is a key that fits into one of those locks. When Spect binds to the lock, it triggers a series of events that ultimately lead to a desired outcome, such as reducing symptoms of a disease. This process is highly specific, meaning Spect only affects the cells it's designed to target.","oneSentence":"Spect works by interacting with a specific biological target to produce a therapeutic effect.","technicalDetail":"Spect's mechanism of action involves binding to a specific protein or receptor, which triggers a downstream signaling cascade that ultimately leads to a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=spect","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=spect","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-31T10:24:50.308386","biosimilars":[],"competitors":[],"genericName":"spect","indications":{"approved":[{"name":"Acute gonococcal cervicitis","diseaseId":"acute-gonococcal-cervicitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal urethritis","diseaseId":"acute-gonococcal-urethritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Disseminated Gonococcal Infection","diseaseId":"disseminated-gonococcal-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea","diseaseId":"gonorrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea of rectum","diseaseId":"gonorrhea-of-rectum","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT06389097","phase":"","title":"SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-02-03","conditions":["Prostate Cancer","Advanced Cancer"],"enrollment":80,"completionDate":"2029-08"},{"nctId":"NCT06888323","phase":"PHASE1","title":"Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-27","conditions":["Refractory Myelodysplastic Syndrome"],"enrollment":30,"completionDate":"2027-12-31"},{"nctId":"NCT06982222","phase":"PHASE1","title":"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-31","conditions":["Anatomic Stage IV Breast Cancer AJCC v8","Metastatic Breast Carcinoma","Metastatic Lung Non-Small Cell Carcinoma","Metastatic Malignant Neoplasm in the Bone","Metastatic Prostate Adenocarcinoma","Stage IV Lung Cancer AJCC v8","Stage IVB Prostate Cancer AJCC v8"],"enrollment":24,"completionDate":"2027-02-12"},{"nctId":"NCT07500987","phase":"PHASE1","title":"Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-02-27","conditions":["EGFR Mutation-positive NSCLC"],"enrollment":12,"completionDate":"2026-07-21"},{"nctId":"NCT04090398","phase":"PHASE2","title":"Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-08-04","conditions":["Anatomic Stage IV Breast Cancer AJCC v8","Metastatic HER2-Negative Breast Carcinoma","Metastatic Malignant Neoplasm in the Bone"],"enrollment":70,"completionDate":"2026-06-30"},{"nctId":"NCT07422363","phase":"PHASE1","title":"Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-28","conditions":["Recurrent Glioblastoma, IDH-Wildtype","Recurrent Gliosarcoma","Recurrent WHO Grade 4 Glioma"],"enrollment":30,"completionDate":"2027-02-28"},{"nctId":"NCT04665739","phase":"PHASE2","title":"Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-02-03","conditions":["Advanced Lung Neuroendocrine Tumor","Functioning Lung Neuroendocrine Tumor","Locally Advanced Lung Neuroendocrine Neoplasm","Lung Neuroendocrine Neoplasm","Lung Neuroendocrine Tumor G1","Lung Neuroendocrine Tumor G2","Metastatic Lung Neuroendocrine Neoplasm","Metastatic Lung Neuroendocrine Tumor","Non-Functioning Lung Neuroendocrine Tumor","Recurrent Lung Neuroendocrine Neoplasm","Unresectable Lung Neuroendocrine Neoplasm","Unresectable Lung Neuroendocrine Tumor"],"enrollment":70,"completionDate":"2033-01-16"},{"nctId":"NCT03841617","phase":"PHASE2","title":"The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2019-07-29","conditions":["Thyroid Cancer"],"enrollment":30,"completionDate":"2035-11-01"},{"nctId":"NCT05451004","phase":"PHASE3","title":"SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2023-02-10","conditions":["Oropharyngeal Cancer"],"enrollment":510,"completionDate":"2031-08-30"},{"nctId":"NCT03017820","phase":"PHASE1","title":"A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-04-04","conditions":["B-Cell Non-Hodgkin Lymphoma","Histiocytic and Dendritic Cell Neoplasm","Myelodysplastic Syndrome","Previously Treated Myelodysplastic Syndrome","Recurrent Adult Acute Myeloid Leukemia","Recurrent Anaplastic Large Cell Lymphoma","Recurrent Angioimmunoblastic T-Cell Lymphoma","Recurrent Mycosis Fungoides","Recurrent Plasma Cell Myeloma","Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma","Recurrent T-Cell Non-Hodgkin Lymphoma","Refractory Acute Myeloid Leukemia","Refractory Anaplastic Large Cell Lymphoma","Refractory Angioimmunoblastic T-Cell Lymphoma","Refractory Mycosis Fungoides","Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified","Refractory Plasma Cell Myeloma","Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma","Refractory T-Cell Non-Hodgkin Lymphoma"],"enrollment":127,"completionDate":"2032-04-01"},{"nctId":"NCT07159074","phase":"PHASE2","title":"Repurposing Tilmanocept for Cardiac Sarcoidosis","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-09-17","conditions":["Cardiac Sarcoidosis"],"enrollment":15,"completionDate":"2026-12-31"},{"nctId":"NCT07241273","phase":"NA","title":"SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer","status":"NOT_YET_RECRUITING","sponsor":"UNICANCER","startDate":"2026-04","conditions":["Oropharyngeal Squamous Cell Carcinoma","Oropharyngeal Cancers","Oropharyngeal Carcinoma","Head and Neck","Head and Neck Cancer","Head and Neck Cancers"],"enrollment":128,"completionDate":"2031-04"},{"nctId":"NCT06526299","phase":"PHASE2","title":"Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-04-29","conditions":["Metastatic Castration-Resistant Prostate Carcinoma","Stage IVB Prostate Cancer AJCC v8"],"enrollment":51,"completionDate":"2027-12-31"},{"nctId":"NCT05863195","phase":"PHASE3","title":"Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2023-10-19","conditions":["Metastatic Colorectal Carcinoma","Metastatic Malignant Neoplasm in the Liver","Stage IV Colorectal Cancer AJCC v8","Unresectable Colorectal Carcinoma"],"enrollment":408,"completionDate":"2034-06-30"},{"nctId":"NCT05283330","phase":"PHASE1","title":"Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors","status":"RECRUITING","sponsor":"Orano Med LLC","startDate":"2022-12-22","conditions":["Cervical Cancer","Breast Cancer","Colon Cancer","NSCLC","mCRPC (Metastatic Castration-resistant Prostate Cancer)","Glioblastoma","Nonsmall Cell Lung Cancer"],"enrollment":48,"completionDate":"2032-05"},{"nctId":"NCT06122610","phase":"PHASE1","title":"Using Novel Imaging to More Safely Treat Neuroendocrine Tumors","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-03-07","conditions":["Neuroendocrine Tumors","Somatostatin Receptor-positive Neuroendocrine Tumor"],"enrollment":10,"completionDate":"2026-06"},{"nctId":"NCT05797870","phase":"PHASE2","title":"Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)","status":"SUSPENDED","sponsor":"Center Eugene Marquis","startDate":"2024-02-14","conditions":["Hepatocellular Carcinoma Non-resectable"],"enrollment":16,"completionDate":"2026-04-14"},{"nctId":"NCT02598219","phase":"PHASE3","title":"Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2015-11","conditions":["Non Endometrioid Carcinoma","Endometrioid Carcinoma"],"enrollment":262,"completionDate":"2027-10"},{"nctId":"NCT05435495","phase":"","title":"Mechanisms of Resistance to PSMA Radioligand Therapy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-10-21","conditions":["Prostate Cancer"],"enrollment":125,"completionDate":"2026-12-31"},{"nctId":"NCT05770349","phase":"","title":"Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure","status":"RECRUITING","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2023-03-31","conditions":["Heart Failure","Coronary Artery Disease"],"enrollment":45,"completionDate":"2027-11"},{"nctId":"NCT07475390","phase":"NA","title":"99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2026-02-15","conditions":["Glioma (Any Grade) in the Brain"],"enrollment":40,"completionDate":"2028-05-31"},{"nctId":"NCT06508463","phase":"PHASE1","title":"Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-01-05","conditions":["Peripheral T Cell Lymphoma","Relapsed Peripheral T-Cell Lymphoma","Peripheral T-Cell Lymphoma, Not Otherwise Specified","Anaplastic Large Cell Lymphoma","Mycosis Fungoides","Relapsed Anaplastic Large Cell Lymphoma","Relapsed Mycosis Fungoides"],"enrollment":21,"completionDate":"2032-04-01"},{"nctId":"NCT01165333","phase":"PHASE1","title":"Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2010-09-06","conditions":["Diffuse Intrinsic Pontine Glioma"],"enrollment":32,"completionDate":"2015-03"},{"nctId":"NCT06812702","phase":"","title":"Parkinson's Disease Biomarker Study","status":"COMPLETED","sponsor":"Ronald Postuma","startDate":"2019-03-05","conditions":["Parkinson Disease, Idiopathic","REM Sleep Behavior Disorder"],"enrollment":230,"completionDate":"2026-03-01"},{"nctId":"NCT04857502","phase":"EARLY_PHASE1","title":"99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2021-04-27","conditions":["Prostate Carcinoma","Recurrent Prostate Carcinoma"],"enrollment":30,"completionDate":"2027-06-01"},{"nctId":"NCT06288113","phase":"PHASE2","title":"Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-08-01","conditions":["Castration-Resistant Prostate Carcinoma","Stage IVB Prostate Cancer AJCC v8"],"enrollment":40,"completionDate":"2028-01-27"},{"nctId":"NCT03996850","phase":"","title":"SPECT/CT for the Characterization of Renal Masses","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2018-12-07","conditions":["Kidney Neoplasm","Renal Mass"],"enrollment":102,"completionDate":"2027-12-31"},{"nctId":"NCT07436988","phase":"PHASE1","title":"Affordable Made-in-India Microspheres for Liver Cancer Therapy","status":"NOT_YET_RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2026-02-15","conditions":["Hepatecellular Carcinoma"],"enrollment":18,"completionDate":"2028-10-15"},{"nctId":"NCT07457541","phase":"PHASE1","title":"Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2026-02-26","conditions":["Lung Cancer (Locally Advanced or Metastatic)","Pancreas Cancer, Metastatic","Breast Cancer (Locally Advanced or Metastatic)","Colorectal Cancer (Locally Advanced or Metastatic)"],"enrollment":15,"completionDate":"2027-05-31"},{"nctId":"NCT05253352","phase":"","title":"Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2022-04-01","conditions":["Lymphatic System"],"enrollment":142,"completionDate":"2026-12"},{"nctId":"NCT05010109","phase":"NA","title":"Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-07-05","conditions":["Locally Advanced Lung Non-Small Cell Carcinoma","Stage III Lung Cancer AJCC v8","Stage IIIA Lung Cancer AJCC v8","Stage IIIB Lung Cancer AJCC v8","Stage IIIC Lung Cancer AJCC v8"],"enrollment":100,"completionDate":"2027-02-02"},{"nctId":"NCT05655312","phase":"PHASE1,PHASE2","title":"MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma","status":"RECRUITING","sponsor":"Perspective Therapeutics","startDate":"2023-06-01","conditions":["Recurrent Melanoma (Skin)","Metastatic Melanoma","Melanoma Stage IV","Melanoma Stage III"],"enrollment":300,"completionDate":"2029-12-31"},{"nctId":"NCT07169825","phase":"NA","title":"Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-13","conditions":["Lu-177 PSMA"],"enrollment":25,"completionDate":"2028-09-01"},{"nctId":"NCT01453127","phase":"PHASE4","title":"DaTSCAN Imaging in Aging and Neurodegenerative Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2011-10","conditions":["Dementia","Parkinsonism","Mild Cognitive Impairment","REM Sleep Behavior Disorder"],"enrollment":500,"completionDate":"2026-12"},{"nctId":"NCT03028311","phase":"PHASE1","title":"Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-01-09","conditions":["Metastatic Liver Carcinoma","Stage IV Liver Cancer","Stage IVA Liver Cancer","Stage IVB Liver Cancer"],"enrollment":12,"completionDate":"2027-01-31"},{"nctId":"NCT06216249","phase":"PHASE2","title":"Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-08-01","conditions":["Prostate Carcinoma","Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8"],"enrollment":90,"completionDate":"2028-12-31"},{"nctId":"NCT06432036","phase":"PHASE1,PHASE2","title":"Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-12-26","conditions":["Stage I Renal Cell Cancer","Stage II Renal Cell Cancer"],"enrollment":25,"completionDate":"2027-06"},{"nctId":"NCT05901545","phase":"PHASE1","title":"Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer","status":"RECRUITING","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2023-08-22","conditions":["Head and Neck Squamous Cell Carcinoma","Recurrent Head and Neck Squamous Cell Carcinoma"],"enrollment":30,"completionDate":"2029-11-30"},{"nctId":"NCT07353463","phase":"","title":"Shanghai Clinical Cohort - Parkinson's Disease (Reserve)","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-04-01","conditions":["Parkinson's Disease (PD)","Multiple System Atrophy"],"enrollment":700,"completionDate":"2026-12-31"},{"nctId":"NCT06147037","phase":"PHASE1","title":"A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-07-31","conditions":["Advanced Solid Tumor","Metastatic Colorectal Carcinoma","Head and Neck Squamous Cell Carcinoma","Non-small Cell Lung Cancer","Pancreatic Ductal Adenocarcinoma","Gastric Cancer","Renal Cell Carcinoma"],"enrollment":70,"completionDate":"2028-05-12"},{"nctId":"NCT06814587","phase":"","title":"Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-07-01","conditions":["Coronary Artery Disease","Coronary Artery Bypass Graft (CABG)"],"enrollment":15,"completionDate":"2026-06-30"},{"nctId":"NCT05912153","phase":"","title":"SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle","status":"RECRUITING","sponsor":"Martini Hospital Groningen","startDate":"2023-07-04","conditions":["Osteoarthritis Ankle","Osteoarthritis"],"enrollment":132,"completionDate":"2027-12"},{"nctId":"NCT06959433","phase":"PHASE3","title":"Lu-177 PSMA Treatment in Cell Renal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Ankara University","startDate":"2026-05-01","conditions":["Metastatic Renal Cancer"],"enrollment":20,"completionDate":"2028-08-01"},{"nctId":"NCT02791204","phase":"","title":"SPECT/CT Imaging of Skeletal Muscle Perfusion","status":"COMPLETED","sponsor":"Yale University","startDate":"2016-05","conditions":["Peripheral Arterial Disease","Diabetes Mellitus"],"enrollment":34,"completionDate":"2026-01-30"},{"nctId":"NCT06944483","phase":"","title":"Same-day Radioembolization for Large HCC","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-04-25","conditions":["Hepatocellular Carcinoma (HCC)"],"enrollment":138,"completionDate":"2029-12-31"},{"nctId":"NCT04676828","phase":"NA","title":"Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2021-12-01","conditions":["Lung Cancer","Radiation-Induced Disorder","Radiation Pneumonitis","Pulmonary Disease","Lung Function Decreased"],"enrollment":90,"completionDate":"2028-12-01"},{"nctId":"NCT06267729","phase":"PHASE1,PHASE2","title":"Study of AZD0754 in Participants With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-03-12","conditions":["Metastatic Prostate Cancer"],"enrollment":60,"completionDate":"2026-11-24"},{"nctId":"NCT07218952","phase":"NA","title":"Radiation Therapy (RT) for Parkinson's Disease (PD)","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2026-04","conditions":["Parkinson's Disease"],"enrollment":20,"completionDate":"2027-10"},{"nctId":"NCT02967848","phase":"","title":"Liver Function Investigation With SPECT","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal North Shore Hospital","startDate":"2016-10-19","conditions":["Liver Cancer, Adult"],"enrollment":20,"completionDate":"2026-12-31"},{"nctId":"NCT05418972","phase":"PHASE2","title":"A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Melanoma Institute Australia","startDate":"2023-08-14","conditions":["Stage II Melanoma"],"enrollment":20,"completionDate":"2035-10"},{"nctId":"NCT07272161","phase":"NA","title":"Pilot Evaluation of the StarGuide Next Generation SPECT/CT System","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-03","conditions":["Nuclear Medicine"],"enrollment":100,"completionDate":"2027-01"},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":["Recurrent Medulloblastoma","Recurrent Ependymoma"],"enrollment":62,"completionDate":"2027-09-30"},{"nctId":"NCT03968679","phase":"NA","title":"Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2019-07-22","conditions":["Head and Neck Cancer"],"enrollment":90,"completionDate":"2028-07-01"},{"nctId":"NCT03120624","phase":"PHASE1","title":"VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-09-15","conditions":["Metastatic Endometrial Carcinoma","Recurrent Endometrial Adenocarcinoma","Recurrent Endometrial Carcinoma","Recurrent Endometrial Clear Cell Adenocarcinoma","Recurrent Endometrial Endometrioid Adenocarcinoma","Recurrent Endometrial Mixed Cell Adenocarcinoma","Recurrent Endometrial Serous Adenocarcinoma","Recurrent Endometrial Undifferentiated Carcinoma","Recurrent Uterine Corpus Carcinosarcoma","Stage IV Uterine Corpus Cancer AJCC v7"],"enrollment":34,"completionDate":"2028-01-01"},{"nctId":"NCT06310590","phase":"PHASE1","title":"Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Chengdu New Radiomedicine Technology Co. LTD.","startDate":"2023-08-08","conditions":["Unresectable Hepatocellular Carcinoma"],"enrollment":40,"completionDate":"2025-06-10"},{"nctId":"NCT07381582","phase":"EARLY_PHASE1","title":"Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":["Prostate Cancer"],"enrollment":15,"completionDate":"2027-12-31"},{"nctId":"NCT07221825","phase":"NA","title":"Low-Count Quantitative SPECT for Men Treated With Radium-223","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-03-01","conditions":["Prostate Cancer","Cancer of the Prostate"],"enrollment":38,"completionDate":"2028-03-31"},{"nctId":"NCT06492122","phase":"PHASE1","title":"Study With [225Ac]Ac-FL-020 in mCRPC Participants","status":"RECRUITING","sponsor":"Full-Life Technologies GmbH","startDate":"2024-08-30","conditions":["Metastatic Castration-resistant Prostate Cancer"],"enrollment":50,"completionDate":"2026-12"},{"nctId":"NCT05401630","phase":"NA","title":"Mental Stress Reactivity in Women With CMD","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-07-19","conditions":["Post-menopause"],"enrollment":150,"completionDate":"2026-12-31"},{"nctId":"NCT06145633","phase":"PHASE2","title":"Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-09-18","conditions":["Castration-Resistant Prostate Carcinoma","Metastatic Prostate Adenocarcinoma","Stage IVB Prostate Cancer AJCC v8"],"enrollment":15,"completionDate":"2027-12-30"},{"nctId":"NCT07370597","phase":"","title":"LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2026-02-01","conditions":["Prostate Cancer (Adenocarcinoma)"],"enrollment":110,"completionDate":"2027-12"},{"nctId":"NCT07358975","phase":"PHASE4","title":"Prediction of Complications in Hepatic Tumors","status":"NOT_YET_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-03","conditions":["Hepatic Tumors"],"enrollment":192,"completionDate":"2028-12"},{"nctId":"NCT06322576","phase":"PHASE2","title":"177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-02-10","conditions":["Adenoid Cystic Carcinoma"],"enrollment":1,"completionDate":"2026-01-20"},{"nctId":"NCT07353333","phase":"NA","title":"Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-01-30","conditions":["HCC","SPECT-CT"],"enrollment":6,"completionDate":"2026-12-30"},{"nctId":"NCT06710756","phase":"PHASE1,PHASE2","title":"Lead-212 PSV359 Therapy for Patients With Solid Tumors","status":"RECRUITING","sponsor":"Perspective Therapeutics","startDate":"2025-04-28","conditions":["Pancreatic Ductal Adenocarcinoma","Gastric Cancer","Esophageal Cancer","Colorectal Cancer","Ovarian Cancer","Head and Neck Cancer","Sarcoma","Mesothelioma"],"enrollment":112,"completionDate":"2032-05-28"},{"nctId":"NCT07341932","phase":"NA","title":"Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-12-27","conditions":["Stable Coronary Artery Disease CAD"],"enrollment":1312,"completionDate":"2027-12-01"},{"nctId":"NCT06039371","phase":"PHASE2","title":"Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-05-21","conditions":["Castration-Resistant Prostate Carcinoma","Metastatic Prostate Adenocarcinoma","Stage IVB Prostate Cancer AJCC v8"],"enrollment":69,"completionDate":"2027-12-31"},{"nctId":"NCT04333537","phase":"PHASE2,PHASE3","title":"Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2020-09-23","conditions":["Buccal Mucosa Squamous Cell Carcinoma","Floor of Mouth Squamous Cell Carcinoma","Gingival Squamous Cell Carcinoma","Hard Palate Squamous Cell Carcinoma","Lip Squamous Cell Carcinoma","Lower Alveolar Ridge Squamous Cell Carcinoma","Oral Cavity Squamous Cell Carcinoma","Retromolar Trigone Squamous Cell Carcinoma","Stage I Lip and Oral Cavity Cancer AJCC v8","Stage II Lip and Oral Cavity Cancer AJCC v8","Tongue Squamous Cell Carcinoma","Upper Alveolar Ridge Squamous Cell Carcinoma"],"enrollment":686,"completionDate":"2031-04-27"},{"nctId":"NCT04362436","phase":"PHASE2","title":"TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-02-05","conditions":["Neuroendocrine Tumors","Liver Metastases"],"enrollment":24,"completionDate":"2023-08-15"},{"nctId":"NCT05239533","phase":"PHASE2","title":"Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-02-16","conditions":["Clear Cell Renal Cell Carcinoma","Kidney Cancer","Advanced Renal Cell Carcinoma"],"enrollment":9,"completionDate":"2027-03"},{"nctId":"NCT07187895","phase":"PHASE2","title":"Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis","status":"TERMINATED","sponsor":"Sinotau Pharmaceutical Group","startDate":"2024-12-19","conditions":["Myocardial Perfusion Imaging","Diagnostic Certainty","Stable Coronary Artery Disease"],"enrollment":17,"completionDate":"2025-03-05"},{"nctId":"NCT07334483","phase":"PHASE2","title":"A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC","status":"RECRUITING","sponsor":"GrandPharma (China) Co., Ltd.","startDate":"2025-08-22","conditions":["HCC"],"enrollment":120,"completionDate":"2027-12-30"},{"nctId":"NCT06257485","phase":"","title":"Bronx Transthyretin Amyloid Cardiomyopathy Database","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2023-09-23","conditions":["Transthyretin Cardiac Amyloidosis","Transthyretin Amyloid Cardiomyopathy"],"enrollment":476,"completionDate":"2026-12"},{"nctId":"NCT07324226","phase":"NA","title":"Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adults","status":"RECRUITING","sponsor":"Pusan National University Yangsan Hospital","startDate":"2026-02-01","conditions":["Healthy Subjects/Volunteers"],"enrollment":9,"completionDate":"2026-12-31"},{"nctId":"NCT05625490","phase":"EARLY_PHASE1","title":"Myocardial Perfusion Imaging Galmydar Rest/Stress","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-11-11","conditions":["Coronary Artery Disease"],"enrollment":15,"completionDate":"2025-12-19"},{"nctId":"NCT04722185","phase":"NA","title":"Evaluation of the Veriton SPECT/CT System","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2021-01-20","conditions":["Focus of Study is Comparison of 2 Types of Gamma Cameras"],"enrollment":41,"completionDate":"2025-12-31"},{"nctId":"NCT02773043","phase":"NA","title":"Evaluation of Myocardial Perfusion Reserve","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2015-12","conditions":["Coronary Artery Disease"],"enrollment":36,"completionDate":"2019-07"},{"nctId":"NCT06828263","phase":"","title":"Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer","status":"RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2023-08-01","conditions":["Prostate Cancer Metastatic Disease"],"enrollment":130,"completionDate":"2043-12"},{"nctId":"NCT04840472","phase":"PHASE1","title":"Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer","status":"SUSPENDED","sponsor":"Stanford University","startDate":"2021-03-30","conditions":["Head and Neck Cancer"],"enrollment":28,"completionDate":"2027-03"},{"nctId":"NCT05103943","phase":"NA","title":"Amyloidosis TTR Flow Reserve Evaluation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2022-02-24","conditions":["Amyloid Cardiomyopathy"],"enrollment":50,"completionDate":"2026-12-11"},{"nctId":"NCT07275463","phase":"PHASE2","title":"[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression","status":"ENROLLING_BY_INVITATION","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2025-10-01","conditions":["Primary Breast Cancer"],"enrollment":40,"completionDate":"2026-12-31"},{"nctId":"NCT03128034","phase":"PHASE1,PHASE2","title":"211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2017-10-24","conditions":["Acute Lymphoblastic Leukemia","Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome","Acute Myeloid Leukemia","Chronic Myelomonocytic Leukemia","Myelodysplastic Syndrome With Excess Blasts","Recurrent Acute Myeloid Leukemia","Refractory Acute Lymphoblastic Leukemia","Recurrent Acute Lymphoblastic Leukemia","Recurrent Mixed Phenotype Acute Leukemia","Refractory Acute Myeloid Leukemia","Refractory Mixed Phenotype Acute Leukemia","Mixed Phenotype Acute Leukemia"],"enrollment":75,"completionDate":"2029-03-31"},{"nctId":"NCT07292571","phase":"PHASE2","title":"Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107","status":"ENROLLING_BY_INVITATION","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2025-10-20","conditions":["Primary Breast Cancer"],"enrollment":50,"completionDate":"2026-03-30"},{"nctId":"NCT02445651","phase":"NA","title":"Physiological Effects of Nutritional Support in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2014-03","conditions":["Parkinson Disease","Idiopathic Parkinson Disease"],"enrollment":51,"completionDate":"2022-08-04"},{"nctId":"NCT04082520","phase":"PHASE2","title":"Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-04-14","conditions":["Grade 1 Meningioma","Grade 2 Meningioma","Grade 3 Meningioma","Recurrent Meningioma","Unresectable Meningioma"],"enrollment":41,"completionDate":"2031-01-06"},{"nctId":"NCT06105918","phase":"PHASE1","title":"Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2023-11-29","conditions":["Biochemically Recurrent Prostate Carcinoma","Prostate Adenocarcinoma"],"enrollment":6,"completionDate":"2029-04-01"},{"nctId":"NCT03921827","phase":"NA","title":"External Counterpulsation Therapy for Severe Steno-occlusive Intracranial Stenosis","status":"COMPLETED","sponsor":"National University of Singapore","startDate":"2019-01-08","conditions":["Ischemic Stroke"],"enrollment":130,"completionDate":"2024-11-30"},{"nctId":"NCT05055206","phase":"NA","title":"Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2021-09-13","conditions":["Oropharynx Cancer"],"enrollment":12,"completionDate":"2023-10-31"},{"nctId":"NCT03579849","phase":"NA","title":"Pulmonary Perfusion by Iodine Subtraction Mapping CT Angiography in Acute Pulmonary Embolism","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2018-06-25","conditions":["Pulmonary Embolism"],"enrollment":30,"completionDate":"2019-04-25"},{"nctId":"NCT05940285","phase":"NA","title":"Evaluation of the Diagnostic Performance of Dynamic Myocardial Perfusion Scintigraphy in Comparison With Invasive Intracoronary FFR Measurement, in the Assessment of Significant Residual Coronary Stenosis After Acute Coronary Syndrome: Dyna-MI Pilot Study.","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2023-10-20","conditions":["Myocardial Infarction"],"enrollment":60,"completionDate":"2027-10-20"},{"nctId":"NCT05366387","phase":"NA","title":"Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2022-11-23","conditions":["Idiopathic Pulmonary Fibrosis"],"enrollment":9,"completionDate":"2025-02-12"},{"nctId":"NCT07054346","phase":"PHASE1","title":"Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617","status":"RECRUITING","sponsor":"Thomas Hope","startDate":"2025-07-08","conditions":["Prostate Cancer","Prostate Cancer (Diagnosis)","High-risk Prostate Cancer","Localized Prostate Carcinoma","Very High Risk Prostate Carcinoma"],"enrollment":45,"completionDate":"2028-04-30"},{"nctId":"NCT06073587","phase":"","title":"The CARDIO-TTRansform Scintigraphy Sub-study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2023-04-04","conditions":["Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)"],"enrollment":150,"completionDate":"2026-03"},{"nctId":"NCT07248033","phase":"","title":"Role of SPECT/CT of Bone Scan in Charactarization of Bone Lesions","status":"NOT_YET_RECRUITING","sponsor":"MennaTalla Saber Sabet Mohamed","startDate":"2025-11","conditions":["Bone Lesions"],"enrollment":120,"completionDate":"2026-12"},{"nctId":"NCT05636618","phase":"PHASE1,PHASE2","title":"Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors","status":"RECRUITING","sponsor":"Perspective Therapeutics","startDate":"2023-09-27","conditions":["Neuroendocrine Tumors Unresectable","Neuroendocrine Tumor Metastatic","Gastroenteropancreatic Neuroendocrine Tumor","Bronchial Neuroendocrine Tumor","Paraganglioma","Pheochromocytoma"],"enrollment":260,"completionDate":"2029-12-26"},{"nctId":"NCT03896646","phase":"NA","title":"Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-10-10","conditions":["Stage III Hepatocellular Carcinoma AJCC v8","Stage IIIA Hepatocellular Carcinoma AJCC v8","Stage IIIB Hepatocellular Carcinoma AJCC v8","Stage IV Hepatocellular Carcinoma AJCC v8","Stage IVA Hepatocellular Carcinoma AJCC v8","Stage IVB Hepatocellular Carcinoma AJCC v8","Unresectable Hepatocellular Carcinoma"],"enrollment":42,"completionDate":"2026-09-30"},{"nctId":"NCT05799092","phase":"NA","title":"Invasive Versus Non-invasive Approach in Symptomatic Patient With Non-High Risk Coronary Artery Stenosis","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2023-10-02","conditions":["Coronary Artery Disease"],"enrollment":2000,"completionDate":"2030-12-31"},{"nctId":"NCT02068794","phase":"PHASE1,PHASE2","title":"MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2014-04-25","conditions":["Fallopian Tube Clear Cell Adenocarcinoma","Fallopian Tube Endometrioid Adenocarcinoma","Fallopian Tube Mucinous Adenocarcinoma","Fallopian Tube Serous Adenocarcinoma","Fallopian Tube Transitional Cell Carcinoma","Fallopian Tube Undifferentiated Carcinoma","Malignant Ovarian Brenner Tumor","Ovarian Clear Cell Adenocarcinoma","Ovarian Endometrioid Adenocarcinoma","Ovarian Mucinous Adenocarcinoma","Ovarian Seromucinous Carcinoma","Ovarian Serous Adenocarcinoma","Ovarian Transitional Cell Carcinoma","Ovarian Undifferentiated Carcinoma","Primary Peritoneal Serous Adenocarcinoma","Recurrent Fallopian Tube Carcinoma","Recurrent Ovarian Carcinoma","Recurrent Primary Peritoneal Carcinoma"],"enrollment":34,"completionDate":"2026-09-01"},{"nctId":"NCT04265209","phase":"PHASE3","title":"[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2021-12-01","conditions":["Parkinson Disease","Essential Tremor"],"enrollment":152,"completionDate":"2024-08-02"},{"nctId":"NCT01800084","phase":"NA","title":"Impact of Reconstruction Method (ASIR, FBP) Used in CT on Bone SPECT/CT Image Quality","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2013-08","conditions":["SPECT-CT"],"enrollment":75,"completionDate":"2014-05-28"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"_patentsChecked":true,"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Tomsk National Research Medical Center of the Russian Academy of Sciences","relationship":"Original Developer"}],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"originalDeveloper":"Tomsk National Research Medical Center of the Russian Academy of Sciences","recentPublications":[{"date":"2026 Mar 28","pmid":"41912136","title":"Gated SPECT Imaging of Left Ventricular Mechanical Dyssynchrony: Predictive Value in Cardiac Resynchronization Therapy Candidates.","journal":"Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology"},{"date":"2026 Mar 23","pmid":"41911406","title":"Gallium-67 SPECT/CT Detection of Lower Extremity Muscle Abscess in Vibrio vulnificus Infection.","journal":"Clinical nuclear medicine"},{"date":"2026 Apr","pmid":"41908703","title":"Nuclear Medicine in Depression: Insights into Brain Metabolism and Treatment Responses: a Literature Review.","journal":"Nuclear medicine and molecular imaging"},{"date":"2026","pmid":"41907604","title":"Clinical efficacy of (99m)Tc-MIBI SPECT/CT compared with CBCT in lung biopsies: a retrospective cohort study.","journal":"Frontiers in oncology"},{"date":"2026 Jun","pmid":"41907062","title":"Discordance Between Striatal Dopaminergic Imaging and Motor Performances in REM Sleep Behavior Disorder.","journal":"Neurology open access"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"active","brandName":"SPECT","companyName":"Tomsk National Research Medical Center of the Russian Academy of Sciences","companyId":"tomsk-national-research-medical-center-of-the-russian-academy-of-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Spect is a small molecule drug developed by the Tomsk National Research Medical Center of the Russian Academy of Sciences. Its target and drug class are unknown, but it is currently owned by the same institution. Spect is off-patent, meaning there are no active patents protecting it. As a result, there are no generic manufacturers of the drug. The commercial status and approved indications of Spect are unclear.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":7,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}